Neuropsychiatric manifestations of systemic lupus erythematosus - A primary disease manifestation

Journal of Neuroimmunology

Volumn 207, Issue 1-2, 2009, Pages 1-2

  Agmon Levin, Nancy ^a   Shaye, Kivity ^a   Shoenfeld, Yehuda ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; PHOSPHOLIPID ANTIBODY; RECEPTOR ANTIBODY; RIBOSOME PROTEIN; RIBOSOME PROTEIN P ANTIBODY; UNCLASSIFIED DRUG;

ANXIETY; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM DISEASE; COGNITION; COGNITIVE DEFECT; CORPUS CALLOSUM; DEPRESSION; EARLY DIAGNOSIS; EDITORIAL; GLOMERULONEPHRITIS; HIPPOCAMPUS; HUMAN; LEARNING DISORDER; MEMORY DISORDER; NERVE CELL LESION; NEUROANATOMY; NONHUMAN; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE;

EID: 60149107048     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.11.006     Document Type: Editorial

References (21)

1. ACR Ad Hoc Committee. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 42 (1999) 599-608
2. Blank M., and Shoenfeld Y. The story of the 16/6 idiotype and systemic lupus erythematosus. Isr. Med. Assoc. J. 10 (2008) 37-39
3. Bonfa E., Golombek S.J., Kaufman L.D., Skelly S., Weissbach H., Brot N., and Elkon K.B. Association between lupus psychosis and anti-ribosomal P protein antibodies. N. Engl. J. Med. 317 (1987) 265-271
4. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., and Diamond B. A subset of lupus anti-DNA Abs cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med. 7 (2001) 1189-1193
5. Emmer B.J., van der Grond J., Steup-Beekman G.M., Huizinga T.W., and van Buchem M.A. Selective involvement of the amygdala in systemic lupus erythematosus. PLoS Med. 3 (2006) e499
6. Gao H.X., Campbell S.R., Cu M.H., Zon P., Hwan J.H., Gulinell M., and Putterman C. Depression is an early manifestation in lupus prone MRL/lpr mice. J. Neuroimmunol. (2009) (Publishers please insert volume and page numbers)
7. Hanly J.G., Urowitz M.B., Siannis F., Farewell V., Gordon C., Bae S.C., Isenberg D., Dooley M.A., Clarke A., Bernatsky S., Gladman D., Fortin P.R., Manzi S., Steinsson K., Bruce I.N., Ginzler E., Aranow C., Wallace D.J., Ramsey-Goldman R., van Vollenhoven R., Sturfelt G., Nived O., Sanchez-Guerrero J., Alarcón G.S., Petri M., Khamashta M., Zoma A., Font J., Kalunian K., Douglas J., Qi Q., Thompson K., and Merrill J.T. Systemic Lupus International Collaborating Clinics. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum. 58 (2008) 843-853
8. Husebye E.S., Sthoeger Z.M., Dayan M., Zinger H., Elbirt D., Levite M., and Mozes E. AutoAbs to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Ann. Rheum. Dis. 64 (2005) 1210-1213
9. Katzav A., Chapman J., and Shoenfeld Y. CNS dysfunction in the antiphospholipid syndrome. Lupus 12 (2003) 903-907
10. Katzav A., Solodeev I., Brodsky O., Chapman J., Pick C.G., Blank M., Zhang W., Reichlin M., and Shoenfeld Y. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arth. & Rheum. 56 (2007) 938-948
11. Kowal C., DeGiorgio L.A., Nakaoka T., Hetherington H., Huerta P.T., Diamond B., and Volpe B.T. Cognition and immunity; antibody impairs memory. Immunity 21 (2004) 179-188
12. Omdal R., Brokstad K., Waterloo K., Koldingsnes W., Jonsson R., and Mellgren S.I. Neuropsychiatric disturbances in SLE are associated with Abs against NMDA receptors. Eur. J. Neurol. 12 (2005) 392-398
13. Rudofsky U.H., and Lawrence D.A. New Zealand mixed mice: a genetic systemic lupus erythematosus model for assessing environmental effects. Environ. Health Perspect. 107 Suppl 5 (1999) 713-721
14. Shoenfeld Y., Nahum A., Korczyn A.D., Dano M., Rabinowitz R., Beilin O., Pick C.G., Leider-Trejo L., Kalashnikova L., Blank M., and Chapman J. Neuronal-binding Abs from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 12 (2003) 436-442
15. Shoenfeld Y. To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system. J. Autoimmun. 28 (2007) 165-169
16. Shoenfeld Y., Blank M., Abu-Shakra M., Amital H., Barzilai O., Berkun Y., Bizzaro N., Gilburd B., Zandman-Goddard G., Katz U., Krause I., Langevitz P., Mackay I.R., Orbach H., Ram M., Sherer Y., Toubi E., and Gershwin M.E. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases. Isr. Med. Assoc. J. 10 (2008) 13-19
17. Strous R.D., and Shoenfeld Y. To smell the immune system: olfaction, autoimmunity and brain involvement. Autoimmun. Rev. 2006 6 (2006) 54-60
18. Toubi E., and Shoenfeld Y. Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun. Rev. 6 (2007) 119-125
19. Unterman, A., Nolte, J.E.S., Boaz, M., Shoenfeld, Y. and Zandman-Goddard, G., Submitted for publication. A meta-analysis of the prevalence of neuropsychiatric syndromes in systemic lupus erythematosus.
20. Zandman-Goddard G., Chapman J., and Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin. Arthritis Rheum. 36 (2007) 297-315
21. Ziporen L., Polak-Charcon S., Korczyn D.A., Goldberg I., Afek A., Kopolovic J., Chapman J., and Shoenfeld Y. Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model. Clin. Dev. Immunol. 11 (2004) 67-75